000 | 01625 a2200421 4500 | ||
---|---|---|---|
005 | 20250515120353.0 | ||
264 | 0 | _c20090331 | |
008 | 200903s 0 0 eng d | ||
022 | _a1460-2377 | ||
024 | 7 |
_a10.1093/intimm/dxn036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJin, Gui-Hua | |
245 | 0 | 0 |
_aCombination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation. _h[electronic resource] |
260 |
_bInternational immunology _cJun 2008 |
||
300 |
_a783-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Genetically Modified |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
650 | 0 | 4 |
_aG(M1) Ganglioside _ximmunology |
650 | 0 | 4 | _aHeparin-binding EGF-like Growth Factor |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 |
_aInterleukin-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
650 | 0 | 4 |
_aMelanoma, Experimental _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Transplantation |
700 | 1 | _aHirano, Toshio | |
700 | 1 | _aMurakami, Masaaki | |
773 | 0 |
_tInternational immunology _gvol. 20 _gno. 6 _gp. 783-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/intimm/dxn036 _zAvailable from publisher's website |
999 |
_c17944825 _d17944825 |